A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
Move-MORE
2 other identifiers
interventional
32
1 country
1
Brief Summary
The Move-MORE study is designed to evaluate a multicomponent mindfulness and movement program for patients with lumbosacral radiculopathy. The program brings together mindfulness training to help participants develop awareness of their body and manage pain-related stress, gentle movement practice to improve comfort with physical activity and support function, and motivational interviewing to strengthen motivation, confidence, and the ability to make healthy changes. The main objectives are to determine whether it is feasible for participants to use each component of the program when delivered online, to assess how acceptable and engaging each component is, and to evaluate the impact on pain, physical function, and daily activity levels. The study intervention will be conducted entirely remotely. Participants will complete online surveys, brief daily check-ins on their phone, and wear a small activity monitor on the hip to measure movement. They will also undergo quantitative sensory testing to evaluate pain sensitivity. At the end of the program, participants will share feedback about their experiences via qualitative interviews. The findings will help identify which parts of the program provide the greatest benefit, with the ultimate goal of developing a more targeted and effective digital program for people with this condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2025
CompletedFirst Posted
Study publicly available on registry
August 15, 2025
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
November 12, 2025
November 1, 2025
1.2 years
August 9, 2025
November 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oswestry Disability Index
Activities of daily living. Min = 0%, Max = 100%. Higher score = worse outcomes.
Week 0, Week 4, Week 8, Week 20
Secondary Outcomes (3)
painDETECT Questionnaire
Week 0, Week 4, Week 8, Week 20
Client Satisfaction Questionnaire
Week 4, Week 8, Week 20
Visual Analog Scale
Daily
Study Arms (1)
Treatment
EXPERIMENTALParticipants will go through the multicomponent Move-MORE program. Move-MORE is an integrated mind-body intervention which combines mindfulness, physical activity, and motivational interviewing informed by the principles of self-determination theory
Interventions
Move-MORE is a multicomponent intervention which combines mindfulness training, physical activity, and motivational interviewing informed by the principles of self-determination theory. The version of Move-MORE being used in this study is specifically designed for use in patients with lumbosacral radiculopathy.
Eligibility Criteria
You may qualify if:
- ● Adults age 18-65 years at the time of enrollment
- Ability to stand for 10 minutes
- Presence of lumbosacral radicular pain within the past week that extends below the knee (i.e., pain radiating from the low back into the leg in a nerve root distribution) with or without accompanying low back pain, of at least 12 weeks' duration, AND
- Tampa Scale of Kinesiophobia score ≥ 23
- At least one positive physical examination finding consistent with lumbosacral radiculopathy, including at least one of the following:
- Positive straight leg raise test (eliciting radicular pain below the knee at ≤70 degrees of elevation);
- Positive Valsalva maneuver (eliciting radiculcar pain below the knee);
- Positive slump test;
- Neurological deficit in a lumbar nerve root distribution, including at least one of the following:
- Dermatomal sensory loss,
- Myotomal weakness, or
- Reduced or absent deep tendon reflexes (e.g., patellar or Achilles reflex) corresponding to the affected nerve root.
- Daily access to the internet via cell phone, tablet, or computer
- Willing to engage with Move-MORE 4-5 times per week on your own
- Willing to attend a two-hour-long virtual Zoom meeting once per week for eight weeks
- +7 more criteria
You may not qualify if:
- ● Participants will be excluded if they have clinical signs or symptoms of lumbosacral radiculopathy with progressive neurologic deficits (loss of motor or sensory function) or intolerable pain.
- Participants with lumbosacral radiculopathy with progressive neurologic deficits will be referred for immediate medical attention, and are not eligible for participation in this study.
- ● Participants will be excluded if they have clinical signs or symptoms suggestive of cauda equina syndrome, including any of the following:
- New-onset urinary retention or overflow incontinence not attributable to other known causes;
- Fecal incontinence;
- New onset of saddle anesthesia (loss of sensation in the buttocks, perineum, and inner thighs);
- Severe or progressive bilateral lower extremity weakness;
- Participants with suspected cauda equina syndrome will be referred for immediate medical attention, and are not eligible for participation in this study.
- Presence of moderate to severe foot drop, defined as noticeable weakness in ankle dorsiflexion that interferes with walking or requires the use of an assistive device (e.g., ankle-foot orthosis). Participants with suspected or worsening foot drop will be referred for further evaluation and are not eligible for study participation.
- Current use of a spinal cord stimulator
- Have received epidural steroid injection in the prior 3 months
- Have received a surgical intervention for low back pain or lumbosacral radiculopathy in the previous 6 months
- Current active mindfulness meditation practice 1 time/week or more, and/or history of formal training in mindfulness/meditation practice
- Concurrent diagnosis of cancer
- Current unmanaged or uncontrolled mental illness known to cause psychosis: schizophrenia, schizotypal disorders, bipolar I disorder with psychosis, major depressive disorder with psychosis
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University of Natural Medicine
Portland, Oregon, 97201, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Research Investigator
Study Record Dates
First Submitted
August 9, 2025
First Posted
August 15, 2025
Study Start
August 15, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
November 12, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- June 2027-
- Access Criteria
- The data that support the findings of this study are available from the corresponding author, R.S.W., upon reasonable request.
The data that support the findings of this study are available from the corresponding author, R.S.W., upon reasonable request.